Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Patients With Acute Coronary Syndrome With Ectatic and Aneurysmatic Coronary Arteries
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 63
- 主要终点
- primary endpoints
研究概览
简要总结
The aim of this study was to evaluate the efficacy and safety of renal stents implanted in ectatic/aneurysmatic coronary arteries.
详细描述
In total, 18 patients (renal stent group) who underwent renal stent implantation in ectatic/aneurysmatic coronary arteries requiring percutaneous coronary intervention (PCI) and 45 patients who underwent large-sized bare metal coronary stent (BMCS) implantation (BMCS group) at our centre between 2015 and 2020 were included in the study. Control coronary angiography (CAG) was performed during the follow-up of these patients, and angiography-guided quantitative measurements were performed during PCI. The primary endpoints were myocardial infarction and cardiovascular mortality, and the secondary endpoints were restenosis and all-cause mortality.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acute coronary syndrome patients
- •18 year age
- •ectatic/aneurysmatic coronary arteries
排除标准
- •Patients who underwent elective procedures,
- •experienced unsuccessful attempts
- •referred to surgical revascularization
研究组 & 干预措施
renal stent group
Acute coronary patients treatment with renal stent
干预措施: Renal stent (Drug)
BMCS group
Acute coronary patients treatment with bare-metal stent
干预措施: Renal stent (Drug)
结局指标
主要结局
primary endpoints
时间窗: 2 year
Rate of myocardial infarction and cardiovascular mortality
次要结局
- secondary endpoints(2 year)
研究者
Hasan ARI
Prof. Dr.
Bursa Postgraduate Hospital